|
|
Volumn 87, Issue 4, 2005, Pages 283-284
|
|
NICE Health Technology Appraisal Programme
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
EXPERIENCE;
HEALTH CARE FINANCING;
HEALTH CARE ORGANIZATION;
HEALTH PROGRAM;
HUMAN;
MEDICAL DECISION MAKING;
MEDICAL EXPERT;
MEDICAL INFORMATION;
MEDICAL TECHNOLOGY;
NOTE;
PATIENT CARE;
PRACTICE GUIDELINE;
SKILL;
TREATMENT OUTCOME;
ARTICLE;
ECONOMICS;
EVIDENCE BASED MEDICINE;
INTENSIVE CARE;
SEPSIS;
CLINICAL TRIAL;
COST EFFECTIVENESS ANALYSIS;
DISEASE SEVERITY;
DRUG DOSE REGIMEN;
DRUG INDICATION;
DRUG MECHANISM;
HOSPITALIZATION;
INTENSIVE CARE UNIT;
LICENSING;
MORTALITY;
MULTIPLE ORGAN FAILURE;
PATIENT SELECTION;
QUALITY ADJUSTED LIFE YEAR;
RISK ASSESSMENT;
SCORING SYSTEM;
BIOMEDICAL TECHNOLOGY;
GREAT BRITAIN;
HUMANS;
PATIENT PARTICIPATION;
TECHNOLOGY ASSESSMENT, BIOMEDICAL;
ANTI-INFECTIVE AGENTS;
EVIDENCE-BASED MEDICINE;
INTENSIVE CARE;
PRACTICE GUIDELINES;
PROTEIN C;
RECOMBINANT PROTEINS;
SEPSIS;
ANTIINFECTIVE AGENT;
DROTRECOGIN;
PROTEIN C;
RECOMBINANT PROTEIN;
PLACEBO;
|
|
EID: 22944442586
PISSN: 00358843
EISSN: None
Source Type: Journal
DOI: 10.1308/003588405X51092 Document Type: Note |
|
Times cited : (1)
|
|
References (1)
|
